Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Mesenchymal stem cells
Elderly
Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
BNT162b2
Elderly
Approved by FDA Experimental Vaccine Jun/22/2022
Convalescent plasma
Elderly
Emergency use authorization Experimental Antiviral May/16/2022
Anakinra 
Elderly
Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Baricitinib
Elderly
Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Tocilizumab
Elderly
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Corticosteroids
Elderly
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021
IVIg
Elderly
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
CoronaVac
Elderly
Potential treatment - clinical evidence Experimental Vaccine Apr/06/2021
Itolizumab
Elderly
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/29/2021
Azithromycin
Elderly
Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021
Antihistamines
Elderly
Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/16/2021